Bicycle Therapeutics Q1 2025: Revenue Up, Net Loss Continues
Ticker: BCYC · Form: 10-Q · Filed: May 1, 2025 · CIK: 1761612
Sentiment: neutral
Topics: 10-Q, financials, biotech, earnings
Related Tickers: BCYC
TL;DR
BCYC Q1 revenue $47.7M, net loss $21.5M. Assets $690.6M, Liabs $69.2M.
AI Summary
Bicycle Therapeutics plc filed a 10-Q for the period ending March 31, 2025. The company reported total assets of $690.6 million and total liabilities of $69.2 million for the quarter. Revenue for the period was $47.7 million, with a net loss of $21.5 million.
Why It Matters
This filing provides a snapshot of Bicycle Therapeutics' financial health and operational performance in early 2025, crucial for investors assessing the company's progress in drug development.
Risk Assessment
Risk Level: medium — As a clinical-stage biopharmaceutical company, Bicycle Therapeutics faces inherent risks related to drug development, regulatory approvals, and market adoption.
Key Numbers
- $690.6M — Total Assets (As of March 31, 2025)
- $69.2M — Total Liabilities (As of March 31, 2025)
- $47.7M — Revenue (For the quarter ended March 31, 2025)
- $21.5M — Net Loss (For the quarter ended March 31, 2025)
Key Players & Entities
- BICYCLE THERAPEUTICS PLC (company) — Filer
- 20250331 (date) — Period of Report
- 20250501 (date) — Filed as of Date
- 69061418 (dollar_amount) — Total Assets
- 69202355 (dollar_amount) — Total Liabilities
- 47710256 (dollar_amount) — Revenue
- 21492099 (dollar_amount) — Net Loss
FAQ
What was Bicycle Therapeutics' total revenue for the quarter ended March 31, 2025?
Bicycle Therapeutics reported total revenue of $47,710,256 for the quarter ended March 31, 2025.
What was the company's net loss for the same period?
The company incurred a net loss of $21,492,099 for the quarter ended March 31, 2025.
What were the total assets of Bicycle Therapeutics as of March 31, 2025?
As of March 31, 2025, Bicycle Therapeutics had total assets of $690,614,18.
What were the total liabilities as of the end of the first quarter of 2025?
Total liabilities for Bicycle Therapeutics as of March 31, 2025, were $69,202,355.
What is the company's fiscal year end?
Bicycle Therapeutics plc's fiscal year ends on December 31.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 1, 2025 regarding BICYCLE THERAPEUTICS PLC (BCYC).